Safety of Autologous Adipose Derived Mesenchymal Stem Cells in Patients With Spinal Cord Injury

Trial Profile

Safety of Autologous Adipose Derived Mesenchymal Stem Cells in Patients With Spinal Cord Injury

Completed
Phase of Trial: Phase I

Latest Information Update: 28 Jul 2015

At a glance

  • Drugs Stem cell therapies (Primary)
  • Indications Spinal cord injuries
  • Focus Adverse reactions
  • Acronyms Astrostem
  • Sponsors K-STEMCELL
  • Most Recent Events

    • 02 Dec 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top